eATP stimulation of RA decreased endothelial function. by Padmini Komalavilas (402160)

The rate of increasing trend in the percentage of Nova Scotia Seniors' Pharmacare Program beneficiaries dispensed rosuvastatin decreased significantly upon the availability of gene... by Laura V. Minard (349145)

The thromboxane analogue, U-46619 decreased vessel diameter. by Simon C. Watkins (39900)

“…Changes in aortic flow velocity (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0044018#pone-0044018-g005" target="_blank">Figure 5</a>) in response to U-46619 in the 5 dpf embryos, were accompanied by decreases in vessel diameter (<b>E</b>, n = 5, <i>P</i><0.05). χ denotes statistical differences from baseline (time 0).…”

High glucose decreases antioxidant activities in endothelial cells. by Zhaoyun Zhang (118032)

“…Measurements were performed as described in Methods. High glucose causes a decrease in multiple antioxidant enzymes. A: G6PD activity. …”

Yta4 decreases the affinity of Dnm1 for GTP. by Jiajia He (795335)

Decreased Notch signaling in the retinoid-deficient spinal cord. by Marie Paschaki (179823)

More focal female offspring produced on dishes where the prior occupant was a related female, while more conspecific offspring were produced on dishes where the female was unrelate... by Emily Rakosy (20939774)

Foldases and holdases each decrease the level of unfolded protein. by Adam MR de Graff (9767829)

Overexpression of Mov10 decreases HIV-1 infectivity. by Vyacheslav Furtak (253807)

Retinoschisin secretion into the conditioned medium is decreased by addition of taxol. by Eiko Kitamura (349087)

“…Retinoschisin secretion into the medium decreases in a dose-dependent manner between 0.5 µM and 10 µM taxol. …”

Rapamycin acts in the brain to decrease body weight gain. by Mark Hebert (558822)

“…<p>A and B: RAP i.c.v. injection (Day 0, broken line) induces a transient decrease in body weight gain (A), which results in prolonged shift in body weight (B). …”

Image_5_Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics.JPEG by Deepti P. Karumathil (5258156)

Image4_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image2_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image6_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image3_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Image7_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.jpeg by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

Table1_Vaccine induced mucosal and systemic memory NK/ILCs elicit decreased risk of SIV/SHIV acquisition.xlsx by Mohammad Arif Rahman (8267352)

“…<p>SIV and HIV-based envelope V1-deleted (ΔV1) vaccines, delivered systemically by the DNA/ALVAC/gp120 platform, decrease the risk of mucosal SIV or SHIV acquisition more effectively than V1-replete vaccines. …”

SP1049C treatment decreases tumor aggressiveness. by Daria Y. Alakhova (447558)